Lawsuits

Novartis, Roche fined €444m in France over eye drug abusive practices

The French Competition Authority has imposed a €444m fine on three drugmakers Novartis, Roche and Genetech for implementing abusive practices to market costly eye injection over a cheaper drug.

French prosecutors file charges against Sanofi over epilepsy drug Depakine

Pharmaceutical firm Sanofi is being investigated by French prosecutors for manslaughter over birth defects associated with an epilepsy drug Depakine.

Johnson & Johnson to appeal opioid judgment in Oklahoma

Johnson & Johnson (NYSE: JNJ) and its Janssen Pharmaceutical Companies today announced they will appeal the $572 million civil judgment entered in Cleveland County District Court in the State of Oklahoma’s lawsuit against opioid manufacturers.

AHF calls on Gilead to set up fund for victims harmed by its TDF-based drugs

AIDS Healthcare Foundation (AHF) is calling on Gilead Sciences Inc., one of the largest manufacturers of HIV/AIDS drugs, to set up a $10 billion victim compensation fund for patients harmed after taking the drug maker’s TDF-based (tenofovir disoproxil fumarate) drugs as part of their treatment for HIV or AIDS or taken by uninfected individuals as part of the HIV prevention strategy known as pre-exposure prophylaxis or PrEP.

Teva reaches agreement with Oklahoma to resolve state’s claims

Teva Pharmaceuticals USA and related affiliates of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and the state of Oklahoma, have entered into an agreement for a one-time payment of $85 million to the state.

Three pharma firms agree to pay $122.6m to settle kickback allegations

Jazz Pharmaceuticals, Lundbeck and Alexion Pharmaceuticals have agreed to pay a total of $122.6m to resolve allegations of paying kickbacks through copay assistance foundations.

Bayer, Janssen settle litigation over blood thinner Xarelto

Bayer has entered into a $775m settlement agreement with Janssen Pharmaceuticals to resolve litigation related with blood thinner medication Xarelto.

FTC, Teva reach global settlement to resolve reverse-payment charges

The US Federal Trade Commission (FTC) and Israel-based Teva Pharmaceuticals Industries have reached a global settlement to resolve three separate federal court antitrust lawsuits involving the latter’s subsidiaries.

US court rejects Indivior’s appeal on Suboxone generic version

The US court has cleared way for Dr. Reddy's Laboratories to launch generic version of Indivior’s Suboxone (buprenorphine and naloxone) sublingual film, which is an opioid addiction treatment.